United States

Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

7 Dec 2016
Change (% chg)

$0.10 (+2.25%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for DSCI.OQ


Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound... (more)


Beta: 0.99
Market Cap(Mil.): $125.80
Shares Outstanding(Mil.): 28.27
Dividend: --
Yield (%): --


  DSCI.OQ Industry Sector
P/E (TTM): -- 55.81 30.77
EPS (TTM): -0.31 -- --
ROI: -7.02 7.05 15.23
ROE: -7.58 10.65 16.56

BRIEF-Derma Sciences Q3 loss per share $0.05

* Derma sciences reports 2016 third quarter financial results

Nov 10 2016

BRIEF-Derma Sciences gets reimbursement coding for medihoney hydrogel dressings

* Derma Sciences receives reimbursement coding for new Medihoney Hydrogel dressings

Aug 25 2016

BRIEF-Derma Sciences names president of advanced wound care

* Derma Sciences names Russell Olsen president of advanced wound care Source text for Eikon: Further company coverage:

Aug 18 2016

BRIEF-Derma Sciences to acquire BIOD

* Derma Sciences to acquire BIOD, solidify its leadership position in advanced wound care and regenerative products

Jul 28 2016

BRIEF-Derma Sciences to sell First-Aid Products division for $12.2 million

* Derma sciences to sell first aid products division for approximately $12.2 million

Jul 27 2016


Earnings vs. Estimates